Patrick Hwu, M.D.

The University of Texas MD Anderson Cancer Center US

Dr Patrick Hwu is Head Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, additionally he is President Elect to the Society for Immunotherapy of Cancer (SITC), 2019-2024. He is a tumor immunologist focused on the areas of vaccines, adoptive T-cell therapies, and immunotherapy resistance. His research and clinical efforts have led to insights and advances in the understanding of the interactions between tumors and the immune system, and the development of cellular therapies. Ongoing clinical trials are being conducted based on his group’s work, including a trial of T-cells gene-modified to enhance resistance against TGF-. Most recently, his preclinical studies have focused on combinations of immune checkpoint blockade and T-cell therapy, as well as rational combinations of targeted therapies and immunotherapies.


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.